Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Youli Zu

Showing results (21-30 of 133) with videos related to

Pageof 14
Sort By:
American Journal of Clinical Pathology|September 22, 2010
Combination of an aptamer probe to CD4 and antibodies for multicolored cell phenotypingPeng Zhang, Nianxi Zhao, Zihua Zeng, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 28, 2014
A tyrosine kinase inhibitor-based high-affinity PET radiopharmaceutical targets vascular endothelial growth factor receptorFeng Li, Sheng Jiang, Youli Zu, et al.
The International Journal of Biochemistry & Cell Biology|March 26, 2014
Blocking interaction of viral gp120 and CD4-expressing T cells by single-stranded DNA aptamersNianxi Zhao, Sung-nan Pei, Parag Parekh, et al.
International Journal of Molecular Sciences|May 31, 2020
Aptamer Cocktail to Detect Multiple Species of Mycoplasma in Cell CultureQuanyuan Wan, Xiaohui Liu, Zihua Zeng, et al.
Genes|June 28, 2023
Classification of Acute Myeloid Leukemia by Cell-Free DNA 5-HydroxymethylcytosineJianming Shao, Shilpan Shah, Siddhartha Ganguly, et al.
Clinical Epigenetics|August 24, 2023
Cell-free DNA 5-hydroxymethylcytosine is highly sensitive for MRD assessment in acute myeloid leukemiaJianming Shao, Shilpan Shah, Siddhartha Ganguly, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 10, 2022
Aptamer-armed nanostructures improve the chemotherapy outcome of triple-negative breast cancerQuanyuan Wan, Zihua Zeng, Jianjun Qi, et al.
Biomaterials|November 21, 2021
Targeted immunotherapy of triple-negative breast cancer by aptamer-engineered NK cellsZhenghu Chen, Zihua Zeng, Quanyuan Wan, et al.
Clinical Chemistry|August 6, 2021
Poor Humoral Response in Solid Organ Transplant Recipients Following Complete mRNA SARS-CoV-2 VaccinationJing Cao, Xiaohui Liu, Alagarraju Muthukumar, et al.
Plos One|January 26, 2016
ssDNA Aptamer Specifically Targets and Selectively Delivers Cytotoxic Drug Doxorubicin to HepG2 CellsGe Yu, Huan Li, Shuanghui Yang, et al.
Pageof 14

Showing results (21-30 of 133) with videos related to

Sort By:
Pageof 14
American Journal of Clinical Pathology|September 22, 2010
Combination of an aptamer probe to CD4 and antibodies for multicolored cell phenotypingPeng Zhang, Nianxi Zhao, Zihua Zeng, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 28, 2014
A tyrosine kinase inhibitor-based high-affinity PET radiopharmaceutical targets vascular endothelial growth factor receptorFeng Li, Sheng Jiang, Youli Zu, et al.
The International Journal of Biochemistry & Cell Biology|March 26, 2014
Blocking interaction of viral gp120 and CD4-expressing T cells by single-stranded DNA aptamersNianxi Zhao, Sung-nan Pei, Parag Parekh, et al.
International Journal of Molecular Sciences|May 31, 2020
Aptamer Cocktail to Detect Multiple Species of Mycoplasma in Cell CultureQuanyuan Wan, Xiaohui Liu, Zihua Zeng, et al.
Genes|June 28, 2023
Classification of Acute Myeloid Leukemia by Cell-Free DNA 5-HydroxymethylcytosineJianming Shao, Shilpan Shah, Siddhartha Ganguly, et al.
Clinical Epigenetics|August 24, 2023
Cell-free DNA 5-hydroxymethylcytosine is highly sensitive for MRD assessment in acute myeloid leukemiaJianming Shao, Shilpan Shah, Siddhartha Ganguly, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 10, 2022
Aptamer-armed nanostructures improve the chemotherapy outcome of triple-negative breast cancerQuanyuan Wan, Zihua Zeng, Jianjun Qi, et al.
Biomaterials|November 21, 2021
Targeted immunotherapy of triple-negative breast cancer by aptamer-engineered NK cellsZhenghu Chen, Zihua Zeng, Quanyuan Wan, et al.
Clinical Chemistry|August 6, 2021
Poor Humoral Response in Solid Organ Transplant Recipients Following Complete mRNA SARS-CoV-2 VaccinationJing Cao, Xiaohui Liu, Alagarraju Muthukumar, et al.
Plos One|January 26, 2016
ssDNA Aptamer Specifically Targets and Selectively Delivers Cytotoxic Drug Doxorubicin to HepG2 CellsGe Yu, Huan Li, Shuanghui Yang, et al.
Pageof 14